HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hartunian, N S Articles by Thompson, M S Search for Related Content PubMed PubMed Citation Articles by Hartunian, N S Articles by Thompson, M S

The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis.

N S Hartunian, C N Smart and M S Thompson

The economic impact of disease and injury has most often been calculated by examining the costs associated with the prevalence of the impairments in the reference year. An alternative accounting approach is to assign all disease costs to the year of incidence, an approach which entails present-valuing to the year of incidence both health care expenditures and lost productivity. The incidence approach is the more appropriate for gauging the economic gains achievable through prevention, immediate rehabilitation, and arresting progression. Incidence-based costs have been estimated for the United States in 1975 for cancer, coronary heart disease, motor vehicle injuries, and stroke. A noteworthy finding is the relative economic importance of motor vehicle injuries, which frequently have been overlooked in the ordering of public health expenditure priorities. After cancer, which generated approximately $23.1 billion in present-valued costs in 1975 (discounted at 6 per cent), motor vehicle injuries and coronary heart disease constitute the next most expensive conditions--having generated estimated annual costs of $14.4 billion and $13.7 billion, respectively. Stroke, at $6.5 billion, follows in economic importance.

This article has been cited by other articles:

				A Garcia-Altes and K Perez The economic cost of road traffic crashes in an urban setting Inj. Prev., February 1, 2007; 13(1): 65 - 68. [Abstract] [Full Text] [PDF]

				S. M.A.A. Evers, J. N. Struijs, A. J.H.A. Ament, M. L.L. van Genugten, J. C. Jager, and G. A.M. van den Bos International Comparison of Stroke Cost Studies Stroke, May 1, 2004; 35(5): 1209 - 1215. [Abstract] [Full Text] [PDF]

				H. M. Dewey, A. G. Thrift, C. Mihalopoulos, R. Carter, R. A.L. Macdonell, J. J. McNeil, and G. A. Donnan Lifetime Cost of Stroke Subtypes in Australia: Findings From the North East Melbourne Stroke Incidence Study (NEMESIS) Stroke, October 1, 2003; 34(10): 2502 - 2507. [Abstract] [Full Text] [PDF]

				S Mulder, W J Meerding, and E F van Beeck Setting priorities in injury prevention: the application of an incidence based cost model Inj. Prev., March 1, 2002; 8(1): 74 - 78. [Abstract] [Full Text] [PDF]

				H. M. Dewey, A. G. Thrift, C. Mihalopoulos, R. Carter, R. A.L. Macdonell, J. J. McNeil, and G. A. Donnan Cost of Stroke in Australia From a Societal Perspective: Results From the North East Melbourne Stroke Incidence Study (NEMESIS) Stroke, October 1, 2001; 32(10): 2409 - 2416. [Abstract] [Full Text] [PDF]

				W. B. Sedrine, L. Radican, and J.-Y. Reginster On conducting burden-of-osteoporosis studies: a review of the core concepts and practical issues. A study carried out under the auspices of a WHO Collaborating Center Rheumatology, January 1, 2001; 40(1): 7 - 14. [Abstract] [Full Text] [PDF]

				R. A. Hirth, M. E. Chernew, E. Miller, A. M. Fendrick, and W. G. Weissert Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard Med Decis Making, July 1, 2000; 20(3): 332 - 342. [Abstract] [PDF]

				B. F. Gage, A. B. Cardinalli, and D. K. Owens Cost-Effectiveness of Preference-Based Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation Stroke, June 1, 1998; 29(6): 1083 - 1091. [Abstract] [Full Text] [PDF]

				J. Lipscomb, M. Ancukiewicz, G. Parmigiani, V. Hasselblad, G. Samsa, and D. B. Matchar Predicting the Cost of Illness: A Comparison of Alternative Models Applied to Stroke Med Decis Making, April 1, 1998; 18(2): S39 - S56. [Abstract] [PDF]

				S. M. A. A. Evers, G. L. Engel, and A. J. H. A. Ament Cost of Stroke in the Netherlands From a Societal Perspective Stroke, July 1, 1997; 28(7): 1375 - 1381. [Abstract] [Full Text]

				H. S. Jorgensen, H. Nakayama, H. O. Raaschou, and T. S. Olsen Acute Stroke Care and Rehabilitation: An Analysis of the Direct Cost and Its Clinical and Social Determinants : The Copenhagen Stroke Study Stroke, June 1, 1997; 28(6): 1138 - 1141. [Abstract] [Full Text]

				C. P. Derdeyn and W. J. Powers Cost-Effectiveness of Screening for Asymptomatic Carotid Atherosclerotic Disease Stroke, November 1, 1996; 27(11): 1944 - 1950. [Abstract] [Full Text]

				T. N. Taylor, P. H. Davis, J. C. Torner, J. Holmes, J. W. Meyer, and M. F. Jacobson Lifetime Cost of Stroke in the United States Stroke, September 1, 1996; 27(9): 1459 - 1466. [Abstract] [Full Text]

				S. Xiaodong Kong and J. Stubbings Assessing the Economic Value of Pharmaceutical Products and Services Journal of Pharmacy Practice, August 1, 1995; 8(4): 143 - 155. [Abstract] [PDF]

				J. N. Clarke Media Portrayal of Disease from the Medical, Political Economy, and Life-Style Perspectives Qual Health Res, August 1, 1991; 1(3): 287 - 308. [Abstract] [PDF]

				C. H. Brooks Cost Differences between Hospice and Nonhospice Care: A Comparison of Insurer Payments and Provider Charges Eval Health Prof, June 1, 1989; 12(2): 159 - 178. [Abstract] [PDF]

				T. Christoffel The Role of Law in Reducing Injury J. Law Med. Ethics, March 1, 1989; 17(1): 7 - 16. [PDF]